The Academy of Managed Care Pharmacy (AMCP) supports comprehensive access to and responsible use of health information and technology to enhance pharmacy practice, improve patient care, and optimize healthcare delivery.
AMCP supports the use of evidence-based formularies, or drug lists, to encourage the use of safe, effective, and affordable medications that meet the needs of the patient population and assist members of the health care team in effectively managing a patient's medication regimen.
The Academy of Managed Care Pharmacy (AMCP) advocates for pharmacists' direct involvement in the development, evaluation, and implementation of evidence-based clinical practice guidelines that focus on an interdisciplinary team approach to patient care.
The Academy of Managed Care Pharmacy (AMCP) recognizes drug utilization review (DUR) as an essential evaluation tool to facilitate the improvement of medication prescribing, administration, and use to enhance patient outcomes and help reduce overall healthcare costs.
The Academy of Managed Care Pharmacy (AMCP) stands against racial and health care injustice. AMCP acknowledges that health care disparities occur across a multitude of factors, including race, ethnicity, gender, and socioeconomics. To increase health care access for all, collecting, evaluating, and incorporating data on race, ethnicity, and socioeconomic factors and evaluating the association of these factors with medication use and access is imperative.
AMCP's perspective on Collaborative Drug Therapy Management (CDTM) in managed care pharmacy. Academy of Managed Care Pharmacy (AMCP) advocates for a collaborative approach to achieving optimal therapeutic outcomes, emphasizing the shared responsibility of the health care team.
The Academy of Managed Care Pharmacy (AMCP) fully endorses the Code of Ethics for Pharmacists established by the American Pharmacists Association (APhA) as the guiding framework for ethical pharmacy practice.
Today, the Congressional Budget Office (CBO) released an updated cost estimate for the One Big, Beautiful Bill Act (H.R. 1). This cost estimate incorporates the amendments made to H.R. 1 in the hours before the House passed the legislation by a vote of 215-214-1.